Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0HIY stock hub

LON/0HIY has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0HIYis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

52.1M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0HIY

In the news

Latest news · LON/0HIY

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/E2.1

P25 15.9P50 22.9P75 35.8

ROEn/a

P25 -54.2P50 2.1P75 13.7

ROICn/a

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0HIY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

170

Groups with data

Currency

USD

Showing 170 of 170 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	14
Employees Change	-139%
Employees Change Percent	-90.85
Enterprise value	$53.5M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	US0465132068
Last refreshed	2026-05-10
Market cap	$52.1M
Price	$8
Price currency	USD
Rev Per Employee	6,409,542.57x
Sector	Healthcare
Sic	2836
Symbol	lon/0HIY
Website	https://www.atarabio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	46.62%
EV Earnings	2.2x
EV/EBIT	1.47x
EV/EBITDA	1.28x
EV/Sales	0.6x
P/B ratio	-1.82x
P/E ratio	2.15x
P/S ratio	0.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	40.96%
EBITDA Margin	42.71%
Gross margin	61.79%
Gross Profit	$55.4M
Gross Profit Growth Q	-92.41%
Net Income	$24.3M
Net Income Growth Quarters	10%
Net Income Growth Years	2%
Pretax Margin	27.09%
Profit Margin	27.07%
Profit Per Employee	$1.7M
Profitable Years	1
ROA	47.81
Roa5y	-26.18
ROCE	931.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	24.45%
Cagr3y	-49.19%
Cagr5y	-51.16%
EPS Growth Quarters	4
EPS Growth Years	1
Revenue Growth	-6.34x
Revenue Growth Q	-95.13x
Revenue Growth Years	0x
Revenue Growth3 Y	23.85x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.87
Assets	$15M
Cash	$6.3M
Current Assets	$9M
Current Liabilities	$10.9M
Debt	$7.7M
Debt EBITDA	$0.18
Equity	$-28.6M
Interest Coverage	13.05
Liabilities	$43.6M
Long Term Assets	$6.1M
Long Term Liabilities	$32.7M
Net Cash	$-1.4M
Net Cash By Market Cap	$-2.7
Net Debt EBITDA	$0.04
Tangible Book Value	$-28.6M
Tangible Book Value Per Share	$-3.91
WACC	6.81

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.82
Net Working Capital	$-7.6M
Quick ratio	0.65
Working Capital	$-2M
Working Capital Turnover	$-2.48

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-69.85%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	24.43%
200-day SMA	10.3
3Y total return	-86.89%
50-day SMA	5.36
50-day SMA vs 200-day SMA	50under200
5Y total return	-97.22%
All Time High	650.5
All Time High Change	-98.58%
All Time High Date	2020-12-08
All Time Low	4.02
All Time Low Change	130.09%
All Time Low Date	2026-02-23
ATR	0.91
Beta	-0.33
Ch YTD	-48.61
High	9.93
High52	19.05
High52 Date	2026-01-05
High52ch	-58.01%
Low	8
Low52	4.02
Low52 Date	2026-02-23
Low52ch	99.1%
Ma50ch	72.39%
Price vs 200-day SMA	-10.26%
RSI	72.95
RSI Monthly	40.92
RSI Weekly	54.32
Sharpe ratio	0.83x
Sortino ratio	1.51
Total Return	-69.85%
Tr YTD	-48.61
Tr1m	94.64%
Tr1w	85.17%
Tr3m	91.81%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$36.8M
Operating margin	40.96

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,688,737%
Net Borrowing	-183,378.5
Shares Insiders	2.32%
Shares Institutions	26.36%
Shares Qo Q	0.42%
Shares Yo Y	69.85%
Short Ratio	0.22

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	52,949.3x
Bv Per Share	-3.91
Ch1m	94.64
Ch1w	85.16
Ch1y	24.43
Ch3m	91.81
Ch3y	-86.89
Ch5y	-97.22
Ch6m	-16.33
Change	-22.71%
Change From Open	-0.87
Close	10.35
Days Gap	-22.03
Depreciation Amortization	1,552,115.6
Dollar Volume	661,928
Earnings Date	2026-05-13
EBIT	$36.8M
EBITDA	$38.3M
EPS	$1.91
F Score	5
Financing CF	11,960,814
Fiscal Year End	December
Founded	2,012
Income Tax	$23,033
Investing CF	13,483,964
Is Primary Listing	0
Last Earnings Date	2026-02-06
Last Report Date	2025-12-31
Last Split Date	2024-06-20
Last Split Type	Reverse
Ma150	9.71
Ma150ch	-4.78%
Ma20	5.5
Ma20ch	68.09%
Net CF	-12,403,642
Next Earnings Date	2026-05-13
Open	8.07
Position In Range	0
Ppne	5,235,089.4
Price Date	2026-05-08
Price EBITDA	$1.36
Relative Volume	1.56x
Revenue	89,733,596x
SBC By Revenue	8.07x
Share Based Comp	7,245,736
Tax By Revenue	0.03x
Tax Rate	0.09%
Tr6m	-16.33%
Volume	82,741
Z Score	-125.3

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0HIY pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0HIY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0HIY?

Insider, institutional, and short-interest positioning.

Institutional ownership

+26.4%

Share of float held by funds and institutions

Insider ownership

+2.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0HIY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

73.0

Above 70: short-term overbought

Price vs 200-day MA

-10.3%

50/200-day relationship not available

Beta (5Y)

-0.33

Less volatile than the market

Sharpe ratio

0.83

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0HIY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0HIY stock rating?

lon/0HIY is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0HIY analysis?

The full report lives at /stocks/lon/0HIY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0HIY?

The latest report frames lon/0HIY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0HIY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.